Development of an inhibitor of an endocannabinoid-degrading enzyme provides insights into the role of 2-arachidonoylglycerol in the nervous system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Di Marzo, V., De Petrocellis, L. & Bisogno, T. Handb. Exp. Pharmacol. 168, 147–185 (2005).
Cravatt, B.F. et al. Proc. Natl. Acad. Sci. USA 98, 9371–9376 (2001).
Lichtman, A.H. et al. J. Pharmacol. Exp. Ther. 311, 441–448 (2004).
Long, J.Z. et al. Nat. Chem. Biol. 5, 37–44 (2009).
Kathuria, S. et al. Nat. Med. 9, 76–81 (2003).
Mackie, K. Annu. Rev. Pharmacol. Toxicol. 46, 101–122 (2006).
Edgemond, W.S., Hillard, C.J., Falck, J.R., Kearn, C.S. & Campbell, W.B. Mol. Pharmacol. 54, 180–188 (1998).
Woodward, D.F. et al. Pharmacol. Ther. 120, 71–80 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marnett, L. Decoding endocannabinoid signaling. Nat Chem Biol 5, 8–9 (2009). https://doi.org/10.1038/nchembio0109-8
Issue Date:
DOI: https://doi.org/10.1038/nchembio0109-8